ABSTRACT
Abstract Coronavirus disease 2019 (COVID-19) is a rapid-spread infectious disease caused by the SARS-CoV-2 virus, which can culminate in the renin-angiotensin-aldosterone (RAAS) and kallikrein-kinin (KKS) systems imbalance, and in serious consequences for infected patients. This scoping review of published research exploring the RAAS and KKS was undertaken in order to trace the history of the discovery of both systems and their multiple interactions, discuss some aspects of the viral-cell interaction, including inflammation and the system imbalance triggered by SARS-CoV-2 infection, and their consequent disorders. Furthermore, we correlate the effects of continued use of the RAAS blockers in chronic diseases therapies with the virulence and physiopathology of COVID-19. We also approach the RAAS and KKS-related proposed potential therapies for treatment of COVID-19. In this way, we reinforce the importance of exploring both systems and the application of their components or their blockers in the treatment of coronavirus disease.
ABSTRACT
Coronavirus disease 2019 (COVID-19) is a rapid-spread infectious disease caused by the SARS-CoV-2 virus, which can culminate in the renin-angiotensin-aldosterone (RAAS) and kallikrein-kinin (KKS) systems imbalance, and in serious consequences for infected patients. This scoping review of published research exploring the RAAS and KKS was undertaken in order to trace the history of the discovery of both systems and their multiple interactions, discuss some aspects of the viral-cell interaction, including inflammation and the system imbalance triggered by SARS-CoV-2 infection, and their consequent disorders. Furthermore, we correlate the effects of continued use of the RAAS blockers in chronic diseases therapies with the virulence and physiopathology of COVID-19. We also approach the RAAS and KKS-related proposed potential therapies for treatment of COVID-19. In this way, we reinforce the importance of exploring both systems and the application of their components or their blockers in the treatment of coronavirus disease.(AU)
Subject(s)
Virulence , Angiotensins , Kallikreins , Coronavirus , Aldosterone , SARS-CoV-2 , InflammationABSTRACT
Objective To study the occurring regulation of antibody of Urbani sever acute respiratory syndrome (SARS)-associated coronavirus after onset of illness in patients with SARS and investigate the co-infection status of Chlamydiae pneumoniae (Chlamydiae P.) , Mycoplasma pneumoniae (Mycoplasma P.), Adenovirus, Respiratory Syncytia virus (RSV). Methods Serum Antibody IgM and IgG of Urbani SARS-associated coronavirus of 43 patients with SARS and 10 patients with other diseases except SARS at the two different phases of illnesses were detected with immune fluorescent technique. Antibody IgM and IgG of Chlamydiae P., Mycoplasma P., Adenovirus and RSV in the above samples were detected with enzyme-linked immunosorbent assay (ELISA). Results 40 cases' infection of were Urbani SARS-associated coronavirus were determined (93.02%) and 3 cases were negative (6.98%). 10 patients with other diseases except SARS have negative serum Antibody IgM and IgG of Urbani SARS-associated coronavirus. Recent infection rates of Chlamydiae P., Mycoplasma P., Adenovirus and RSV were 25.58%, 16.28%, 6.98% and 4.65% , respectively, and former infection rates of these pathogens were 39.53%, 34.88%, 27.91% and 0, respectively. Antibody IgM of Urbani SARS-associated coronavirus occurred at the same time of onset of fever. Positive rates of IgM were respectively 69.57% and 62.96% in 8～14 days and 15～33 days after onset of fever, and there were no remarkable difference between them, but they were re-markably higher than that in 1～7 days after onset of fever (16.67%). Antibody IgG of Urbani SARS-as-sociated coronavirus occurred at the 6th day after onset of fever. Positive rates of IgG were respectively 19.44%, 65.22% and 92.59% in 1～7 days, 8～14 days and 15～33 days after onset of fever, and there were remarkable difference among them. Conclusions Antibody IgM and IgG of Urbani SARS-associated coronavirus may occur at the early stage of illness in patientswith SARS, which positive cases may increase remarkably 2 weeks later after onset of fever. There may be recent infection and/or former infection of Chlamydiae P., Mycoplasma P., Adenovirus and RSV in some patients with infectious atypical pneumonia. Detection of Antibody IgM and IgG of Urbani SARS-associated coronavirus in sera with immune fluorescent technique can be used on the early diagnosis of SARS.
ABSTRACT
Objective To study the expression of SARS-associated coronavirus nucleocapsid(N) gene in Pichia pastoris and to obtain recombinant N protein with good biological activity.Methods The gene encoding the full N protein of SARS-CoV was amplified by PCR and cloned into Pichia pastoris expression vector pPICZA.The recombinant expression plasmid pPICZA/N was transformed into X-33,KM71H and GS115. The positive insert transformants were screened,cultured and induced by methanol.The recombinant protein was further purified with Ni affinity chromatography.Antigen activity was detected with anti-N monoclonal antibody,polyclonal antibody and sera from SRAS patients.Results SDS-PAGE and immunological analysis demonstrated that only Pichia pastoris transformants KM71H/pPICZA/N and X-33/pPICZA/N expressed Mr 70 000 fusion protein with special antigenicity.Conclusion SARS-CoV N protein expression in Pichia pastoris has been achieved,establishing the basis for further study of biological and immunological function of N antigen.